NeuroPace, Inc. (NPCE)
14.41
+0.28
(+1.98%)
USD |
NASDAQ |
Aug 28, 16:00
14.43
+0.02
(+0.14%)
After-Hours: 20:00
NeuroPace Cash from Operations (Quarterly) : -3.903M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.903M |
| March 31, 2026 | -5.90M |
| December 31, 2025 | 0.506M |
| September 30, 2025 | -1.944M |
| June 30, 2025 | -2.086M |
| March 31, 2025 | -7.482M |
| December 31, 2024 | -4.797M |
| September 30, 2024 | -1.724M |
| June 30, 2024 | -3.90M |
| March 31, 2024 | -7.528M |
| December 31, 2023 | -3.341M |
| September 30, 2023 | -2.302M |
| June 30, 2023 | -4.36M |
| Date | Value |
|---|---|
| March 31, 2023 | -9.698M |
| December 31, 2022 | -7.843M |
| September 30, 2022 | -6.975M |
| June 30, 2022 | -10.66M |
| March 31, 2022 | -11.39M |
| December 31, 2021 | -8.203M |
| September 30, 2021 | -4.424M |
| June 30, 2021 | -6.014M |
| March 31, 2021 | -5.936M |
| December 31, 2020 | -6.424M |
| September 30, 2020 | -5.425M |
| June 30, 2020 | -3.212M |
| March 31, 2020 | -6.548M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -34.63M |
| CVRx, Inc. | -8.826M |
| Accuray, Inc. | 2.427M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -6.147M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.125M |
| Cash from Financing (Quarterly) | 1.176M |
| Free Cash Flow | -11.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1181 |
| Free Cash Flow to Equity (Quarterly) | -3.497M |
| Free Cash Flow to Firm (Quarterly) | -2.489M |
| Free Cash Flow Yield | -2.40% |